The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: a systematic mapping review

BACKGROUND: The presence of circulating cell-free DNA from tumours in blood (ctDNA) is of major importance to those interested in early cancer detection, as well as to those wishing to monitor tumour progression or diagnose the presence of activating mutations to guide treatment. In 2014, the UK Ear...

Descripción completa

Detalles Bibliográficos
Autores principales: Cree, Ian A., Uttley, Lesley, Buckley Woods, Helen, Kikuchi, Hugh, Reiman, Anne, Harnan, Susan, Whiteman, Becky L., Philips, Sian Taylor, Messenger, Michael, Cox, Angela, Teare, Dawn, Sheils, Orla, Shaw, Jacqui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5654013/
https://www.ncbi.nlm.nih.gov/pubmed/29061138
http://dx.doi.org/10.1186/s12885-017-3693-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5654013/
https://www.ncbi.nlm.nih.gov/pubmed/29061138
http://dx.doi.org/10.1186/s12885-017-3693-7

Ejemplares similares